Cargando…

Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Lemonnier, E, Villeneuve, N, Sonie, S, Serret, S, Rosier, A, Roue, M, Brosset, P, Viellard, M, Bernoux, D, Rondeau, S, Thummler, S, Ravel, D, Ben-Ari, Y
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2017
Materias:	Corrigendum
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5534937/ https://www.ncbi.nlm.nih.gov/pubmed/28485727 http://dx.doi.org/10.1038/tp.2017.101

Ejemplares similares

Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders
por: Lemonnier, E, et al.
Publicado: (2017)

A randomised controlled trial of bumetanide in the treatment of autism in children
por: Lemonnier, E, et al.
Publicado: (2012)

A Wholistic View of How Bumetanide Attenuates Autism Spectrum Disorders
por: Delpire, Eric, et al.
Publicado: (2022)

Bumetanide for autism: more eye contact, less amygdala activation
por: Hadjikhani, Nouchine, et al.
Publicado: (2018)

Failure of the Nemo Trial: Bumetanide Is a Promising Agent to Treat Many Brain Disorders but Not Newborn Seizures
por: Ben-Ari, Yehezkel, et al.
Publicado: (2016)

Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
por: Crutel, Véronique, et al.
Publicado: (2020)

Atypical sulcal anatomy in young children with autism spectrum disorder
por: Auzias, G., et al.
Publicado: (2014)

Correction to: Bumetanide Oral Liquid Formulation for the Treatment of Children and Adolescents with Autism Spectrum Disorder: Design of Two Phase III Studies (SIGN Trials)
por: Crutel, Véronique, et al.
Publicado: (2021)

Bumetanide Therapeutic Effect in Children and Adolescents With Autism Spectrum Disorder: A Review Study
por: Mollajani, Raheleh, et al.
Publicado: (2019)

Nanoformulated Bumetanide Ameliorates Social Deficiency in BTBR Mice Model of Autism Spectrum Disorder
por: Lv, Hui, et al.
Publicado: (2022)

Bumetanide for autism: Open‐label trial in six children
por: Fernell, Elisabeth, et al.
Publicado: (2021)

Treatment Effect of Bumetanide in Children With Autism Spectrum Disorder: A Systematic Review and Meta-Analysis
por: Wang, Tiantian, et al.
Publicado: (2021)

The immuno-behavioural covariation associated with the treatment response to bumetanide in young children with autism spectrum disorder
por: Li, Qingyang, et al.
Publicado: (2022)

Children with autism spectrum disorders and selective mutism [Corrigendum]
Publicado: (2018)

Successive clinical application of vitamin D and bumetanide in children with autism spectrum disorder: A case report
por: Feng, Jun-Yan, et al.
Publicado: (2020)

Reduced subcortical glutamate/glutamine in adults with autism spectrum disorders: a [(1)H]MRS study
por: Horder, J, et al.
Publicado: (2014)

Lithium as a rescue therapy for regression and catatonia features in two SHANK3 patients with autism spectrum disorder: case reports
por: Serret, Sylvie, et al.
Publicado: (2015)

Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios
por: Zhang, Lingli, et al.
Publicado: (2020)

Correction: Symptom improvement in children with autism spectrum disorder following bumetanide administration is associated with decreased GABA/glutamate ratios
por: Zhang, Lingli, et al.
Publicado: (2020)

Teaching Literacy Skills to French Minimally Verbal School-Aged Children with Autism Spectrum Disorders with the Serious Game SEMA-TIC: An Exploratory Study
por: Serret, Sylvie, et al.
Publicado: (2017)

The GABA Polarity Shift and Bumetanide Treatment: Making Sense Requires Unbiased and Undogmatic Analysis
por: Ben-Ari, Yehezkel, et al.
Publicado: (2022)

Maternally inherited genetic variants of CADPS2 are present in Autism Spectrum Disorders and Intellectual Disability patients
por: Bonora, Elena, et al.
Publicado: (2014)

Neurobehavioral phenotype of autism spectrum disorder associated with germline heterozygous mutations in PTEN
por: Busch, Robyn M., et al.
Publicado: (2019)

Motor Functional Characteristics in Attention-Deficit/Hyperactivity Disorder and Autism Spectrum Disorders: A Systematic Review [Corrigendum]
Publicado: (2022)

Corrigendum to “The Efficacy and Safety of Acupuncture for the Treatment of Children with Autism Spectrum Disorder: A Systematic Review and Meta-Analysis”
por: Lee, Boram, et al.
Publicado: (2023)

Neurobehavioral Associations with NREM and REM Sleep Architecture in Children with Autism Spectrum Disorder
por: Nguyen, Jennifer, et al.
Publicado: (2022)

Functional characterization of FABP3, 5 and 7 gene variants identified in schizophrenia and autism spectrum disorder and mouse behavioral studies
por: Shimamoto, Chie, et al.
Publicado: (2015)

Bumetanide Exposure Association with Alzheimer’s Disease Risk
por: Graber-Naidich, Anna, et al.
Publicado: (2023)

Bumetanide: Metabolic alkalosis: case report
Publicado: (2021)

Off-Label Use of Bumetanide for Brain Disorders: An Overview
por: Kharod, Shivani C., et al.
Publicado: (2019)

Evaluation of bumetanide as a potential therapeutic agent for Alzheimer’s disease
por: Boyarko, Ben, et al.
Publicado: (2023)

Disorder-specific functional abnormalities during sustained attention in youth with Attention Deficit Hyperactivity Disorder (ADHD) and with Autism
por: Christakou, A, et al.
Publicado: (2013)

Bumetanide for neonatal seizures: No light in the pharmacokinetic/dynamic tunnel
por: Kaila, Kai, et al.
Publicado: (2022)

Failure of bumetanide to improve outcome after intracerebral hemorrhage in rat
por: Wilkinson, Cassandra M., et al.
Publicado: (2019)

Corrigendum to “Pediatric Traumatic Brain Injury and Autism: Elucidating Shared Mechanisms”
por: Singh, Rahul, et al.
Publicado: (2017)

Corrigendum: Extended-spectrum β-lactamase-producing and carbapenemase-producing Enterobacteriaceae
por: Wilson, Hayley, et al.
Publicado: (2018)

Bumetanide Suppression of Angiogenesis in a Rat Model of Oxygen-Induced Retinopathy
por: Guzel, Sibel, et al.
Publicado: (2020)

A retrospective evaluation of the efficacy of intravenous bumetanide and comparison of potency with furosemide
por: Nappi, Jean M.
Publicado: (2013)

Corrigendum: Chromatin structure influences rate and spectrum of spontaneous mutations in Neurospora crassa
por: Villalba de la Peña, Mariana, et al.
Publicado: (2023)

Bumetanide Prevents Brain Trauma-Induced Depressive-Like Behavior
por: Goubert, Emmanuelle, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_4v6bs9crppn66go12oc37nia7m